Also in global health news: Malawi HIV/AIDS fight; cancer in developing world

NewsGuard 100/100 Score

Malawi Gets $30M World Bank Grant For HIV/AIDS

Tim Gilbo, the World Bank's director in Malawi, announced on Tuesday that the organization will grant the country $30 million, which will be used to "increase access to prevention, treatment and mitigation services with a focus on behavioural change," SAPA/News24.com reports. Gilbo also said the country should "identify and promote those programmes that are working and drop or redesign those that are not bearing any fruits." UNAIDS Malawi coordinator Desmond Johns said HIV/AIDS is "arguably the single consistent threat in overall development" for Malawi (9/22).

Report Warns Of Developing World Cancer 'Tsunami'

Reuters examines the burden of cancer in developing countries, which receive "only about 5 percent of global resources for cancer," despite comprising "60 percent of last year's 7.6 million cancer deaths," experts say. A report on cancer, released as experts on the disease are meeting in Berlin, says cancer kills more people in developing countries "than tuberculosis, malaria and AIDS combined and a 'tsunami' of the disease threatens to overwhelm the nations worst equipped to cope" (Kelland, 9/22).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer